Prolacta Bioscience Introduces Prolact+6 H2MF® in a New 15 mL Volume
Type: Press Releases
Enrollment Passes Halfway Milestone in Clinical Trial Evaluating the Effect of an Exclusive Human Milk Diet Including a Specialty Fortifier in Term Infants Born with Single Ventricle Congenital Heart Defects
Type: Press Releases
New Analysis Published in the Journal Breastfeeding Medicine Finds Additional Clinically Significant Benefits From an Exclusive Human Milk Diet in the NICU
Type: Press Releases
Starting 100 Percent Human Milk-Based Fortifier Early Is Associated With Improved Growth in Extremely Premature Infants, According to an Independent Study
Type: Press Releases
Prolacta Bioscience Salutes World Breast Milk Donation Day May 19
Type: Press Releases
Prolacta Bioscience to Present at the Cowen and Company 38th Annual Health Care Conference on March 14, 2018
Type: Press Releases
Prolacta Bioscience Earns LEED Gold Certification for New Headquarters in Duarte
Type: Press Releases
Prolacta Bioscience Launches Easier-to-Read Labels for its Human Milk-Based Neonatal Nutritional Products
Type: Press Releases
Prolacta Bioscience Supports Prematurity Awareness Month with New Educational Resources for Parents of Preemies
Type: Press Releases
